Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Sep 30, 2004 2:41am
105 Views
Post# 7984801

RE: Anyone getting anxious yet?

RE: Anyone getting anxious yet?I think we will get something tommorrow as promised. Any guesses as to the good / bad or indifferent at this point is pure conjecture but its not going to stop me from throwing my hat in the ring! My gut feel from management is that rAAT specifically has been downplayed in the last two quarters. This can be read as a precursor to average or poor results OR ( and I like this supposition better ) it can be read that management feels that this whole rAAT excercise is inconsequential relative to the BLOCKBUSTER opportunity of PBI-1402 ! I get the feeling that there's something good cooking in that regard. Ruttan: I thought Pierre's discussion regarding the apparent opportunity tabled to sell one of the therapeutic compounds for the equivalent of the market cap of the company was a reference to PBI1402. Ironically that discussion was when the stock was $2.25 so I guess that means its worth TWICE the market cap now all things being equal ! Regardless of what happens tommorrow, my humble prediction is that the stock will be meaningfully higher a month from now and anything in between should be seen as an opportunity. good luck all
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse